193 related articles for article (PubMed ID: 16523297)
1. Expression of p63 and p16 in primary and recurrent pterygia.
Ramalho FS; Maestri C; Ramalho LN; Ribeiro-Silva A; Romão E
Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1310-4. PubMed ID: 16523297
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium.
Assimakopoulou M; Pagoulatos D; Nterma P; Pharmakakis N
Mol Med Rep; 2017 Oct; 16(4):5285-5293. PubMed ID: 28849159
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b.
Chen PL; Cheng YW; Chiang CC; Tseng SH; Chau PS; Tsai YY
Mol Vis; 2006 Nov; 12():1411-6. PubMed ID: 17149367
[TBL] [Abstract][Full Text] [Related]
4. Expression of Peroxiredoxin 2 and Vascular Endothelial Growth Factor Receptor 2 in Pterygium.
Wang Y; Lin J; Chen L; Wang L; Hao P; Han R; Ying M; Li X
Cornea; 2017 Jul; 36(7):841-844. PubMed ID: 28489720
[TBL] [Abstract][Full Text] [Related]
5. Proliferative activity and p53 expression in primary and recurrent pterygia.
Chowers I; Pe'er J; Zamir E; Livni N; Ilsar M; Frucht-Pery J
Ophthalmology; 2001 May; 108(5):985-8. PubMed ID: 11320032
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate.
Gumus K; Karakucuk S; Mirza GE; Akgun H; Arda H; Oner AO
Br J Ophthalmol; 2014 Jun; 98(6):796-800. PubMed ID: 23376569
[TBL] [Abstract][Full Text] [Related]
7. EphrinB2 and EphB4 expression in pterygia: new insights and preliminary results.
Xue C; Huang Z; Wang J; Dong Y; Zhou X
Can J Ophthalmol; 2009 Apr; 44(2):185-8. PubMed ID: 19491953
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells.
Dushku N; Reid TW
Curr Eye Res; 1994 Jul; 13(7):473-81. PubMed ID: 7924411
[TBL] [Abstract][Full Text] [Related]
9. Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium.
Kase S; Takahashi S; Sato I; Nakanishi K; Yoshida K; Ohno S
Br J Ophthalmol; 2007 Jul; 91(7):958-61. PubMed ID: 17179165
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometry measurements of DNA content in primary and recurrent pterygia.
Tan DT; Liu YP; Sun L
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1684-6. PubMed ID: 10845586
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft.
Kheirkhah A; Hashemi H; Adelpour M; Nikdel M; Rajabi MB; Behrouz MJ
Ophthalmology; 2012 Feb; 119(2):227-32. PubMed ID: 22153864
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of p53 tumor suppressor gene in pterygia.
Weinstein O; Rosenthal G; Zirkin H; Monos T; Lifshitz T; Argov S
Eye (Lond); 2002 Sep; 16(5):619-21. PubMed ID: 12194078
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression in primary and recurrent pterygium.
Karahan N; Baspinar S; Ciris M; Baydar CL; Kapucuoglu N
Indian J Ophthalmol; 2008; 56(4):279-83. PubMed ID: 18579985
[TBL] [Abstract][Full Text] [Related]
14. P63 expression in conjunctival proliferative diseases: pterygium and laryngo-onycho-cutaneous (LOC) syndrome.
Atkinson SD; Moore JE; Shah S; Sharma A; Best RM; Leccisotti A; Alarbi M; Rimmer D; Gardiner T; Moore TC
Curr Eye Res; 2008 Jul; 33(7):551-8. PubMed ID: 18600487
[TBL] [Abstract][Full Text] [Related]
15. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells.
Di Girolamo N; Kumar RK; Coroneo MT; Wakefield D
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3430-7. PubMed ID: 12407153
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and function of survivin during the progress of pterygium.
Xu YX; Zhang LY; Zou DL; Liu ZS; Shang XM; Wu HP; Zhou Y; He H; Liu ZG
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8480-7. PubMed ID: 25468890
[TBL] [Abstract][Full Text] [Related]
17. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells.
Di Girolamo N; McCluskey P; Lloyd A; Coroneo MT; Wakefield D
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):671-9. PubMed ID: 10711680
[TBL] [Abstract][Full Text] [Related]
18. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells.
Dushku N; John MK; Schultz GS; Reid TW
Arch Ophthalmol; 2001 May; 119(5):695-706. PubMed ID: 11346397
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17 and its correlation with vascular endothelial growth factor expression in ocular surface pathologies: a histologic study.
Jabarin B; Solomon A; Amer R
Eur J Ophthalmol; 2016 Jun; 26(4):283-6. PubMed ID: 26615952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
